WEIR:LSEWeir Group PLC Analysis
Data as of 2026-06-12 - not real-time
£2,278.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The Weir Group’s share price of 2,278 GBp sits well below its 20‑day (2,421 GBp) and 200‑day (2,866 GBp) moving averages, while the RSI of 31.5 signals oversold conditions and the MACD remains in a bearish configuration. Technical pressure is evident, with price hovering just above the identified support at 2,254 GBp and a sizable resistance barrier near 2,570 GBp. Despite this, the latest Q1 2026 update showed a modest 4% year‑on‑year order growth and analysts have lifted the median target to 3,300 GBp, implying a potential upside of over 40% from current levels. The DCF‑derived fair value of roughly 1,034 GBp suggests the market is pricing in significant premium, flagging the stock as overvalued on a fundamental basis. The company delivers a 1.83% dividend yield with a comfortable 44% payout ratio, supported by solid operating cash flow and a free cash flow conversion of about 12% of revenue. Overall, while short‑term price dynamics are bearish, the underlying earnings momentum, attractive dividend profile, and analyst optimism provide a compelling case for a medium‑term buying stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish technical indicators (RSI, MACD, price below SMAs)
- Proximity to near‑term support at 2,254 GBp
- Recent 15% price drop creating short‑term uncertainty
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst median price target of 3,300 GBp indicating >40% upside
- Quarterly order growth of 4% and improving forward PE to 15.3x
- Sustainable dividend yield of 1.83% with a 44% payout ratio
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong cash generation and moderate leverage (debt‑to‑equity ~93%)
- Exposure to global mining and industrial sectors with digital services upside
- Valuation premium relative to DCF fair value suggesting price correction risk
Key Metrics & Analysis
Financial Health
Revenue Growth5.50%
Profit Margin9.63%
P/E Ratio24.0
ROE13.14%
ROA6.23%
Debt/Equity93.08
P/B Ratio3.1
Op. Cash Flow£385.4M
Free Cash Flow£239.7M
Industry P/E30.4
Technical Analysis
TrendBearish
RSI31.5
Support£2,254.00
Resistance£2,570.00
MA 20£2,421.38
MA 50£2,677.27
MA 200£2,866.03
MACDBearish
VolumeStable
Fear & Greed Index86.71
Valuation
Fair Value£1,034.18
Target Price£3,264.52
Upside/Downside43.31%
GradeOvervalued
TypeBlend
Dividend Yield1.83%
Risk Assessment
Beta0.50
Volatility33.27%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.